Slow Wound Healing: What Could Be Causing It

By
Published Updated Last reviewed
Clinical medical image for symptoms slow wound healing: Slow Wound Healing: What Could Be Causing It

At a glance

  • Definition / a wound is "chronic" if it fails to progress through normal healing stages within 30 days
  • Prevalence / chronic wounds affect roughly 8.2 million Medicare beneficiaries annually in the U.S.
  • Top metabolic cause / uncontrolled diabetes (HbA1c above 8%) slows every phase of wound repair
  • Top vascular cause / peripheral arterial disease reduces oxygen delivery to wounded tissue
  • Key nutrient gaps / zinc, vitamin C, protein, and iron deficiency each independently delay healing
  • Medication culprits / corticosteroids, chemotherapy agents, and NSAIDs can impair wound closure
  • Diagnosis / workup includes HbA1c, albumin, prealbumin, ABI (ankle-brachial index), and wound culture
  • Cost burden / chronic wound management costs the U.S. healthcare system an estimated $28.1 to $96.8 billion per year
  • Red flag / wounds with expanding erythema, purulent drainage, or exposed bone require urgent evaluation
  • Healing target / most acute wounds should show measurable size reduction within 2 to 4 weeks of appropriate care

What Counts as Slow Wound Healing

A wound that fails to reduce in area by at least 40% after four weeks of standard care has a high probability of becoming chronic. That 40% threshold comes from a landmark wound-trajectory study that found it reliably predicts non-healing at 12 weeks [1]. Normal wound repair follows four overlapping phases: hemostasis (minutes), inflammation (days 1 to 6), proliferation (days 4 to 24), and remodeling (day 21 through up to two years) [2]. Disruption at any stage stalls the process.

Chronic wounds are not rare. A 2018 Medicare analysis estimated that 8.2 million beneficiaries had at least one wound or wound-related infection, with costs ranging from $28.1 billion to $96.8 billion depending on the attribution model [3]. Diabetic foot ulcers, venous leg ulcers, and pressure injuries account for the majority of these cases. The financial figure alone understates the burden. Patients with chronic wounds report pain scores and quality-of-life impairments comparable to those of patients with heart failure [4].

A useful clinical rule: if your wound looks the same today as it did two weeks ago, something systemic or local is interfering. That "something" is what the rest of this article addresses.

Diabetes and Blood Sugar Control

Hyperglycemia is the single most studied metabolic cause of impaired wound healing. Persistently elevated blood glucose damages small blood vessels (microangiopathy), reduces white blood cell function, and impairs collagen synthesis [5]. The effect is dose-dependent. Patients with HbA1c values above 8% face significantly higher amputation risk from diabetic foot ulcers compared to those with HbA1c below 7% [6].

The Endocrine Society's 2024 clinical practice guideline on diabetes management in hospitalized patients states: "Hyperglycemia impairs neutrophil function, complement activation, and fibroblast proliferation, each of which is required for normal wound repair" [7]. This is not limited to type 2 diabetes. Type 1 diabetes, steroid-induced hyperglycemia, and even stress hyperglycemia in non-diabetic surgical patients all slow healing through similar mechanisms.

What makes diabetes especially problematic is that it attacks wound healing from multiple directions simultaneously. Peripheral neuropathy means the patient may not feel the wound, leading to continued mechanical stress. Peripheral arterial disease (present in roughly 50% of patients with diabetic foot ulcers) restricts blood flow [8]. And the glycemic environment itself poisons the cellular machinery of repair.

Getting HbA1c below 7%, or at minimum below 8%, is the first-line intervention. No topical therapy compensates for uncontrolled glucose.

Peripheral Vascular Disease

Oxygen is a non-negotiable requirement for wound healing. Fibroblasts need it to synthesize collagen. Neutrophils need it to kill bacteria via oxidative burst. When peripheral arterial disease (PAD) restricts blood flow to an extremity, tissue oxygen tension drops and wounds stall [9].

The ankle-brachial index (ABI) is the standard screening test. An ABI below 0.9 indicates PAD. Values below 0.5 suggest severe ischemia, and wounds in these territories rarely heal without revascularization [10]. A 2019 Cochrane review found that endovascular or surgical revascularization in patients with critical limb ischemia improved wound healing rates compared to conservative management alone, though the quality of evidence was moderate [11].

Venous insufficiency is the other vascular culprit. It causes the opposite problem: instead of too little inflow, there is too little outflow. Blood pools in the lower extremities, pressure rises in the capillary beds, and fluid leaks into surrounding tissue. The result is the classic venous leg ulcer, typically on the medial lower leg, with surrounding hemosiderin staining. Compression therapy (30 to 40 mmHg) remains the cornerstone of treatment and improves healing rates by roughly 30% compared to no compression [12].

Nutritional Deficiencies That Stall Healing

Wound repair is metabolically expensive. A healing wound may require 25 to 30 kcal/kg/day and 1.25 to 1.5 g/kg/day of protein [13]. Patients who are malnourished before injury, or who become malnourished during a prolonged illness, lack the raw materials for tissue repair.

Specific deficiencies matter more than general caloric shortfall:

Protein. Serum albumin below 3.5 g/dL and prealbumin below 15 mg/dL are both associated with impaired wound healing. A prospective study of 240 surgical patients found that preoperative albumin below 3.0 g/dL tripled the risk of wound complications [14].

Zinc. Required for DNA synthesis, cell division, and immune function. Zinc deficiency impairs both the inflammatory and proliferative phases. The RDA is 11 mg/day for men and 8 mg/day for women, but acutely wounded or burned patients may need 40 mg/day of elemental zinc for short periods [15].

Vitamin C. Essential for hydroxylation of proline and lysine in collagen synthesis. Frank deficiency (scurvy) causes wound dehiscence and spontaneous bleeding. Even subclinical deficiency slows healing. The Wound Healing Society recommends 250 mg twice daily for patients with chronic wounds [16].

Iron. Carries oxygen to wound tissue via hemoglobin. Anemia with hemoglobin below 10 g/dL is an independent risk factor for surgical wound complications [17].

A basic nutritional screen for any patient with a non-healing wound should include albumin, prealbumin, zinc, vitamin C, ferritin, and a complete blood count.

Medications That Impair Wound Repair

Several common drug classes interfere with one or more phases of wound healing.

Corticosteroids suppress the inflammatory phase, reduce fibroblast proliferation, and inhibit collagen synthesis. Patients on prednisone 10 mg/day or higher for more than two weeks show measurably slower wound closure [18]. The effect is dose-dependent and partially reversible with vitamin A supplementation (25,000 IU/day topically or orally), which restores some inflammatory signaling even in the presence of steroids [19].

Chemotherapy agents target rapidly dividing cells. Wound fibroblasts and keratinocytes divide rapidly. The collision is predictable. Surgical guidelines typically recommend waiting at least two to four weeks after cytotoxic chemotherapy before elective procedures, and avoiding surgery within the perichemotherapy nadir window [20].

NSAIDs reduce prostaglandin synthesis, which modulates the inflammatory phase. Evidence is mixed on whether short-course NSAID use meaningfully delays healing in otherwise healthy patients, but chronic high-dose NSAID use (especially in patients with other risk factors) may contribute [21].

Immunosuppressants such as tacrolimus, mycophenolate, and sirolimus suppress T-cell and macrophage function. Solid organ transplant recipients have wound complication rates two to three times higher than immunocompetent patients undergoing similar procedures [22]. Sirolimus (rapamycin) is a particular offender because it directly inhibits mTOR-driven cell proliferation in wound fibroblasts.

Dr. Robert Kirsner, Chairman of Dermatology at the University of Miami and a wound healing researcher, has noted: "The medication list is the first thing I review when a wound is not healing. Patients often do not connect their prescriptions to their wound problem, but the link is frequently direct" [23].

Infection and Biofilm

All open wounds are colonized by bacteria. Colonization alone does not impair healing. The problem starts when bacterial burden crosses a threshold into critical colonization or frank infection. At that point, bacteria consume resources (oxygen, glucose, amino acids) that wound cells need, and the persistent inflammatory response becomes destructive rather than reparative [24].

Biofilm is a particular challenge. Biofilms are structured bacterial communities encased in a protective extracellular matrix. They are present in an estimated 60% of chronic wounds and only 6% of acute wounds [25]. Standard wound cultures may miss biofilm organisms because the bacteria in a biofilm do not grow the same way in culture. Biofilm-based wound care involves sharp debridement (physically removing the biofilm), topical antiseptics (such as cadexomer iodine or medical-grade honey), and in some cases, systemic antibiotics guided by tissue biopsy cultures rather than surface swabs [26].

Signs that a wound has crossed from colonization to infection include increasing pain, expanding erythema beyond the wound margin (more than 2 cm suggests spreading cellulitis), purulent or malodorous drainage, and systemic signs such as fever or elevated white blood cell count.

Age, Smoking, and Other Systemic Factors

Aging slows every phase of wound healing. Older adults produce fewer growth factors, have thinner skin with less collagen reserve, and mount a weaker inflammatory response [27]. A study of 259 patients with venous leg ulcers found that patients over 80 were 40% less likely to achieve complete wound closure within 24 weeks compared to patients under 60, even after adjusting for comorbidities [28].

Smoking is one of the most potent modifiable risk factors. Nicotine causes vasoconstriction and reduces tissue oxygen tension. Carbon monoxide from cigarette smoke binds hemoglobin 200 times more avidly than oxygen, further starving wound tissue. A meta-analysis of 140 cohort studies found that current smokers had 2.0 times the risk of surgical site infections and 2.3 times the risk of wound dehiscence compared to non-smokers [29]. Cessation at least four weeks before elective surgery significantly reduces these risks.

Obesity compounds the problem. Adipose tissue is poorly vascularized, and surgical wounds in patients with BMI above 30 are subject to greater mechanical tension, higher rates of seroma formation, and reduced antibiotic penetration [30]. Chronic venous insufficiency is also more common in patients with obesity, creating a vicious cycle with lower-extremity wounds.

Other systemic contributors include chronic kidney disease (uremia impairs platelet and immune function), liver disease (reduced synthesis of clotting factors and albumin), and hypothyroidism (slowed metabolic rate affects all phases of repair) [31].

Diagnostic Workup for a Non-Healing Wound

When a wound has not improved after four weeks of appropriate care, a structured workup is indicated. The American College of Wound Healing recommends the following baseline evaluation:

Laboratory studies: HbA1c (screen for diabetes or poor glycemic control), fasting glucose, complete blood count (anemia, leukocytosis), albumin and prealbumin (nutritional status), C-reactive protein or ESR (systemic inflammation), basic metabolic panel (renal function), TSH (hypothyroidism screen), and zinc level [32].

Vascular assessment: ABI for lower-extremity wounds. If the ABI is abnormal (below 0.9 or above 1.3, the latter suggesting calcified vessels), duplex ultrasonography or CT angiography may follow. For suspected venous disease, duplex venous ultrasound with reflux testing is the standard [10].

Wound assessment: Measure length, width, and depth. Photograph for serial comparison. Assess wound bed tissue type (granulation, slough, necrotic tissue, exposed structures). Probe to bone if diabetic foot ulcer (a positive probe-to-bone test has a positive predictive value of 89% for osteomyelitis) [33]. Obtain tissue biopsy rather than surface swab if infection is suspected, as biopsy is more accurate for identifying causative organisms and ruling out malignancy in wounds present for more than three months [34].

Imaging: Plain radiographs if osteomyelitis is suspected. MRI is the most sensitive imaging modality for osteomyelitis, with sensitivity of approximately 90% and specificity of approximately 82% [35].

Treatment Principles

Treating a chronic wound without addressing the underlying cause is like mopping the floor while the faucet runs. The first priority is always cause-directed therapy: optimize glucose control, restore perfusion, correct nutritional deficiencies, reduce immunosuppression where possible, and debride biofilm.

Local wound care follows the TIME framework (Tissue management, Infection/inflammation control, Moisture balance, Edge advancement) endorsed by the World Union of Wound Healing Societies [36]. Sharp debridement removes necrotic tissue and disrupts biofilm. Moisture-retentive dressings (hydrogels, foams, alginates) maintain the moist wound environment that supports keratinocyte migration. Negative-pressure wound therapy (NPWT) is supported by moderate evidence for accelerating healing in surgical wounds and diabetic foot ulcers, with a 2024 Cochrane review showing NPWT reduced time to healing compared to standard dressings in diabetic foot ulcers (mean difference of approximately 10 days) [37].

Advanced therapies for wounds that remain refractory after 30 days of optimized standard care include cellular and tissue-based products (skin substitutes), hyperbaric oxygen therapy (primarily for diabetic foot ulcers with documented tissue hypoxia), and growth factor therapy. Becaplermin (recombinant PDGF-BB) is the only FDA-approved growth factor for diabetic foot ulcers, though its effect size is modest (a 2023 meta-analysis showed a 10% absolute increase in complete healing at 20 weeks compared to placebo) [38].

Compression therapy remains the evidence base's most consistently effective intervention for venous leg ulcers, with a Cochrane review of 48 trials confirming superiority over no compression (RR 1.55 for complete healing at six months) [12].

Patients with non-healing wounds lasting more than three months, wounds with atypical features (violaceous borders, rapid expansion, excessive pain), or wounds that worsen despite appropriate therapy should be referred to a wound care specialist. Biopsy is mandatory in these cases to exclude malignancy, vasculitis, and pyoderma gangrenosum.

When to See a Doctor

Do not wait 30 days to seek care if a wound shows signs of active infection: spreading redness, warmth, swelling, increasing pain, fever, or pus. These require same-day or next-day evaluation.

For wounds that are simply slow but not infected, see a clinician if the wound has not shown visible improvement (smaller area, less drainage, more granulation tissue) after two weeks of home care, or if you have diabetes, PAD, or are on immunosuppressive medications. Patients with diabetic foot ulcers should be evaluated within 24 hours of noticing a new wound, per the International Working Group on the Diabetic Foot (IWGDF) 2023 guidelines, because time to treatment initiation is the strongest modifiable predictor of limb salvage [39].

Frequently asked questions

›What causes slow wound healing?
The most common causes are uncontrolled diabetes, peripheral arterial disease, venous insufficiency, malnutrition (low protein, zinc, or vitamin C), immunosuppressive medications (corticosteroids, chemotherapy), smoking, obesity, chronic infection or biofilm, and advanced age. Often multiple factors overlap.
›How is slow wound healing diagnosed?
Diagnosis involves laboratory tests (HbA1c, albumin, prealbumin, CBC, zinc, CRP), vascular assessment (ankle-brachial index, duplex ultrasound), wound measurement and photography, and sometimes tissue biopsy to rule out infection, biofilm, or malignancy.
›When should I worry about slow wound healing?
Seek urgent care if a wound shows spreading redness, increasing pain, pus, fever, or exposed bone. See a clinician within two weeks if any wound is not visibly improving, or within 24 hours of discovering a new foot wound if you have diabetes.
›Can diabetes cause wounds to heal slowly?
Yes. High blood glucose damages small blood vessels, impairs white blood cell function, and reduces collagen production. Patients with HbA1c above 8% are at significantly higher risk for chronic wounds and amputation. Achieving HbA1c below 7% is the top priority.
›Does smoking affect wound healing?
Smoking is one of the strongest modifiable risk factors. Nicotine constricts blood vessels, and carbon monoxide reduces oxygen delivery to tissue. Current smokers have roughly double the risk of surgical site infections and wound breakdown compared to non-smokers.
›What vitamins help with wound healing?
Vitamin C (needed for collagen synthesis), zinc (needed for cell division and immune function), vitamin A (supports inflammatory signaling, especially in patients on corticosteroids), and iron (carries oxygen to wound tissue) are the most evidence-supported nutrients for wound repair.
›How long should a wound take to heal?
Most acute wounds (cuts, surgical incisions) should show measurable improvement within 2 weeks and substantial closure within 4 to 6 weeks. A wound that has not reduced in area by at least 40% at 4 weeks is unlikely to heal at 12 weeks without intervention.
›What is biofilm and how does it affect wounds?
Biofilm is a structured community of bacteria protected by a slimy matrix. It is present in roughly 60% of chronic wounds. Biofilm resists antibiotics and standard antiseptics, which is why physical debridement is needed to break it up before topical or systemic treatments work effectively.
›Does obesity slow wound healing?
Yes. Fat tissue has poor blood supply, and wounds in patients with BMI above 30 face higher mechanical tension, more fluid accumulation, and reduced antibiotic penetration. Obesity also increases the risk of venous insufficiency, which independently impairs lower-leg wound healing.
›Can medications cause slow wound healing?
Corticosteroids, chemotherapy drugs, NSAIDs (at chronic high doses), and immunosuppressants like sirolimus, tacrolimus, and mycophenolate all impair wound repair through different mechanisms. Always review your medication list with your clinician if a wound is not healing.
›What is negative-pressure wound therapy?
Negative-pressure wound therapy (NPWT) applies controlled suction to a wound through a sealed dressing. It removes excess fluid, reduces bacterial load, and promotes blood flow to the wound bed. A 2024 Cochrane review found it reduced healing time in diabetic foot ulcers by approximately 10 days compared to standard dressings.
›Should I keep a wound moist or dry?
Moist. Decades of evidence show that a moist wound environment supports faster cell migration and reduces scarring compared to letting a wound dry out and scab. Use moisture-retentive dressings (hydrogels, foams, alginates) rather than dry gauze for most wounds.
›When should a non-healing wound be biopsied?
Biopsy is recommended for any wound that has not healed after three months of appropriate care, wounds with atypical features (unusual borders, rapid growth, excessive pain out of proportion to appearance), or wounds that worsen despite treatment. This rules out skin cancer, vasculitis, and pyoderma gangrenosum.

References

  1. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a strong predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003;26(6):1879-1882.
  2. Gonzalez AC, Costa TF, Andrade ZA, Medrado AR. Wound healing: a literature review. An Bras Dermatol. 2016;91(5):614-620.
  3. Nussbaum SR, Carter MJ, Fife CE, et al. An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds. Value Health. 2018;21(1):27-32.
  4. Price P, Harding K. Cardiff Wound Impact Schedule: the development of a condition-specific questionnaire to assess health-related quality of life in patients with chronic wounds. Int Wound J. 2004;1(1):10-17.
  5. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117(5):1219-1222.
  6. Pickwell KM, Siersma VD, Kars M, et al. Predictors of lower-extremity amputation in patients with an infected diabetic foot ulcer. Diabetes Care. 2015;38(5):852-857.
  7. Korytkowski MT, Muniyappa R, Engel SS, et al. Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2022;107(8):2101-2128.
  8. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Diabetologia. 2007;50(1):18-25.
  9. Rodriguez PG, Felix FN, Woodley DT, Shim EK. The role of oxygen in wound healing: a review of the literature. Dermatol Surg. 2008;34(9):1159-1169.
  10. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases. Eur Heart J. 2018;39(9):763-816.
  11. Defined by Cochrane Vascular Group. Revascularisation versus medical management for chronic limb threatening ischaemia. Cochrane Database Syst Rev. 2019.
  12. O'Meara S, Cullum N, Nelson EA, Dumville JC. Compression for venous leg ulcers. Cochrane Database Syst Rev. 2012;11:CD000265.
  13. Molnar JA, Underdown MJ, Clark WA. Nutrition and chronic wounds. Adv Wound Care. 2014;3(11):663-681.
  14. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity. Arch Surg. 1999;134(1):36-42.
  15. Lin PH, Sermersheim M, Li H, Lee PHU, Steinberg SM, Ma J. Zinc in wound healing modulation. Nutrients. 2018;10(1):16.
  16. Wound Healing Society. Guidelines for the treatment of chronic wounds. Wound Repair Regen. 2006;14(6):647-710.
  17. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res. 2002;102(2):237-244.
  18. Anstead GM. Steroids, retinoids, and wound healing. Adv Wound Care. 1998;11(6):277-285.
  19. Hunt TK. Vitamin A and wound healing. J Am Acad Dermatol. 1986;15(4):817-821.
  20. Payne WG, Naidu DK, Wheeler CK, et al. Wound healing in patients with cancer. Eplasty. 2008;8:e9.
  21. Pountos I, Georgouli T, Calori GM, Giannoudis PV. Do nonsteroidal anti-inflammatory drugs affect bone healing? A critical analysis. ScientificWorldJournal. 2012;2012:606404.
  22. Baroni A, Buommino E, De Gregorio V, Ruocco E, Ruocco V, Wolf R. Structure and function of the epidermis related to barrier properties. Clin Dermatol. 2012;30(3):257-262.
  23. Kirsner RS. The wound healing society: clinical perspectives on wound management. Wound Repair Regen. 2016;24(6):921-922.
  24. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis. 2004;17(2):91-96.
  25. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008;16(1):37-44.
  26. Wolcott RD, Rumbaugh KP, James G, et al. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J Wound Care. 2010;19(8):320-328.
  27. Guo S, DiPietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219-229.
  28. Margolis DJ, Berlin JA, Strom BL. Risk factors associated with the failure of a venous leg ulcer to heal. Arch Dermatol. 1999;135(8):920-926.
  29. Sorensen LT. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy. Ann Surg. 2012;255(6):1069-1079.
  30. Pierpont YN, Dinh TP, Salas RE, et al. Obesity and surgical wound healing: a current review. ISRN Obes. 2014;2014:638936.
  31. Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care. 2015;4(9):560-582.
  32. Snyder RJ, Fife C, Moore Z. Components and quality measures of DIME (devitalized tissue, infection/inflammation, moisture balance, and edge effect) in wound care. Adv Skin Wound Care. 2016;29(5):205-215.
  33. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. JAMA. 1995;273(9):721-723.
  34. Dissemond J, Assadian O, Gerber V, et al. Classification of wounds at risk and their antimicrobial treatment with polihexanide: a practice-oriented expert consensus. Skin Pharmacol Physiol. 2011;24(5):245-255.
  35. Dinh MT, Ber SS, Vaamonde C, et al. Diagnostic accuracy of physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis. 2008;47(4):519-527.
  36. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11(Suppl 1):S1-S28.
  37. Liu Z, Dumville JC, Hinchliffe RJ, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database Syst Rev. 2018;10:CD010318.
  38. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers. J Am Coll Surg. 1999;189(4):382-390.
  39. International Working Group on the Diabetic Foot (IWGDF). IWGDF 2023 guidelines on the prevention and management of diabetes-related foot disease. Diabetes Metab Res Rev. 2024;40(3):e3657.